Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Sanofi (Exubera)

M&A STATUS
Asset Purch. LATEST DEAL TYPE
1 FINANCING ROUNDS
Description

Worldwide rights of Exubera, an inhaled, dry powder form of human insulin. Exubera is a rapid-acting, dry powder human insulin that is inhaled through the mouth into the lungs prior to eating, using a portable, handheld inhaler.

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Pharmaceuticals and Biotechnology
Acquirer
Primary Office
  • Frankfurt
  • Germany

Sanofi (Exubera) Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Sanofi (Exubera)‘s full profile, request access.

Request full access to PitchBook

Sanofi (Exubera) Former Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Sanofi (Exubera)‘s full profile, request access.

Request full access to PitchBook